Nephrotoxic Effects in High-Risk Patients Undergoing Angiography
High-risk patients undergoing angiography are susceptible to nephrotoxic effects. This randomized, double-blind, prospective study evaluated the frequency of nephropathy in patients with diabetes and base-line serum creatinine concentrations of 1.5 to 3.5 mg per deciliter. They received either the iso-osmolar, dimeric, nonionic contrast medium iodixanol or the low-osmolar, nonionic, monomeric contrast medium iohexol. The increase in creatinine and the rate of frank nephropathy were significantly lower among those who received the iso-osmolar agent. High-risk patients may be less likely to have contrast-mediuminduced nephropathy when iso-osmolar contrast is used.
|
|||||
Signaling Molecules in Pulmonary Hypertension
Proliferation of smooth-muscle cells in pulmonary arterioles is central to the pathogenesis of pulmonary hypertension. In this study, a signaling pathway involved in smooth-muscle proliferation was found to be altered in patients with nonfamilial forms of pulmonary hypertension. The pathway includes angiopoietin-1, a molecule that signals the recruitment of smooth-muscle cells, its receptor TIE2, and bone morphogenetic protein receptor type 2. Previous studies have shown that mutations in bone morphogenetic protein receptor type 2 may cause familial forms of pulmonary hypertension. The current research links mechanisms involved in both familial and nonfamilial forms of pulmonary hypertension.
|
|||||
Cocaine-Associated Chest Pain
These findings support the safety of short-term, "rule-out" protocols for low-to-intermediate-risk patients who have chest pain associated with cocaine use. However, the high rate of cardiovascular events among cocaine-using patients who were admitted to the hospital underscores the need for careful evaluation of chest pain in this population.
|
|||||
HPV Types Associated with Cervical Cancer
The results of this international study have important implications for the design of vaccines against HPV and the planning of efficient strategies to screen women for high-risk HPV types.
|
|||||
Genetics and Response to Drugs
There is substantial variability among individual patients in the responses to pharmaceutical agents. Among the sources of variation in response are genetic differences in the enzymes responsible for drug metabolism, differences in the targets of the drug, and differences in genes that lead to side effects. Two articles in this issue a Genomic Medicine article and a Drug Therapy review discuss a number of clinically relevant inherited variants that affect drug action or side effects; the study of such variants forms the basis of the field of pharmacogenetics.
|
|||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2010 Massachusetts Medical Society. All rights reserved. |